Hepatotoxicity and Anti-osteoporotic Mechanism of Evodiamine
|更新时间:2025-01-16
|
Hepatotoxicity and Anti-osteoporotic Mechanism of Evodiamine
增强出版
“The latest research has found that evodiamine has anti osteoporosis activity at a safe dose, providing reference for clinical safe drug use and new drug development.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 4, Pages: 79-86(2025)
LI JIAQI, CHEN XIAOLU, TAO XIAOYU, et al. Hepatotoxicity and Anti-osteoporotic Mechanism of Evodiamine. [J]. Chinese journal of experimental traditional medical formulae, 2025, 31(4): 79-86.
DOI:
LI JIAQI, CHEN XIAOLU, TAO XIAOYU, et al. Hepatotoxicity and Anti-osteoporotic Mechanism of Evodiamine. [J]. Chinese journal of experimental traditional medical formulae, 2025, 31(4): 79-86. DOI: 10.13422/j.cnki.syfjx.20241315.
Hepatotoxicity and Anti-osteoporotic Mechanism of Evodiamine增强出版
Evaluation of Anti-osteoporosis Activity and Hepatotoxicity of Xianling Gubao Based on Zebrafish Model
Evaluation of Safety of Compound Kushen Injection and Efficacy in Treatment of Inflammatory Bowel Disease Based on Zebrafish Model
Study on Mechanism of Action of Matrine in Treatment of Inflammatory Bowel Disease Based on Zebrafish Model and Network Pharmacology
Related Author
LI Jiaqi
CHEN Xiaolu
TAO Xiaoyu
LU Shan
FAN Qiqi
WU Jiarui
ZHAO Chongjun
LI Qiuman
Related Institution
Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medical/Traditional Chinese Medicine Processing Technology Inheritance Base of National Administration of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine
School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine
School of Clinical Medicine, Nanjing University
National Institute for Food and Drug Control
Beijing Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine